Is a complete NSE/SUNPHARMA research report available?

No complete published report is available for nse/SUNPHARMA (NSE/SUNPHARMA) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

nse/SUNPHARMA stock profile: metrics, valuation and analysis

Market cap	4.4T
Revenue (ttm)	599.1B
Net income (ttm)	121B
EPS (ttm)	₹50.4
Shares out	2.4B
P/E (trailing)	36.5x
P/E (forward)	34.0x
Dividend	₹16.0 (0.83%)
Volume	1,445,013
Beta	0.12

All NSE/SUNPHARMA indicators

Market & fundamental data

Available fields

232

Groups with data

Currency

INR

Showing 232 of 232 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	47,000
Employees Change	4,000%
Employees Change Percent	9.3
Enterprise value	INR 4.1T
Exchange	National Stock Exchange of India
Financial currency	INR
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Industry PE	39.33
Industry PE Fwd	33.69
Isin	INE044A01036
Last refreshed	2026-09-12
Market cap	INR 4.4T
Price	INR 1,841
Price currency	INR
Rev Per Employee	12,746,919.15x
Sector	Healthcare
Sector PE	47.81
Sector PE Fwd	38.12
Sic	2834
Symbol	nse/SUNPHARMA
Website	https://sunpharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.74%
EV Earnings	34.14x
EV/EBIT	30.05x
EV/EBITDA	24.73x
EV/FCF	46.87x
EV/Sales	6.89x
FCF yield	2%
Forward P/E	34.01x
P/B ratio	5.26x
P/E ratio	36.51x
P/S ratio	7.37x
PE Ratio10 Y	42.69x
PE Ratio3 Y	37.38x
PE Ratio5 Y	40x
PEG ratio	2.32x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	23.03%
EBITDA Margin	27.68%
FCF margin	15.07%
Gross margin	78.92%
Gross Profit	INR 472.8B
Gross Profit Growth	12.37%
Gross Profit Growth Q	11.78%
Gross Profit Growth3 Y	11.74%
Gross Profit Growth5 Y	12.48%
Net Income	INR 121B
Net Income Growth	16.62%
Net Income Growth Q	27.04%
Net Income Growth Qo Q	6.66%
Net Income Growth Quarters	4%
Net Income Growth Years	5%
Net Income Growth3 Y	12.77%
Net Income Growth5 Y	15.04%
Pretax Margin	26.69%
Profit Margin	20.19%
Profit Per Employee	INR 2.6M
Profitable Quarters	INR 17
Profitable Years	23
Roa5y	8.08
Roe5y	13.56
ROIC	19.01
Roic5y	18.3

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	9.66%
Cagr15y	15.29%
Cagr1y	16.58%
Cagr20y	17.45%
Cagr3y	18.71%
Cagr5y	20.03%
Div CAGR10	31.95%
Div CAGR3	11.64%
Div CAGR5	16.36%
EPS Growth	16.54
EPS Growth Q	27.37
EPS Growth Qo Q	7.5
EPS Growth Quarters	4
EPS Growth Years	5
EPS Growth3 Y	12.82
EPS Growth5 Y	15.06
FCF Growth	-26.24%
FCF Growth3 Y	45.27%
FCF Growth5 Y	11.99%
OCF Growth	-11.75%
OCF Growth10 Y	6.39%
OCF Growth3 Y	35.8%
OCF Growth5 Y	15.02%
Revenue Growth	11.41x
Revenue Growth Q	10.46x
Revenue Growth Qo Q	4.71x
Revenue Growth Quarters	24x
Revenue Growth Years	8x
Revenue Growth3 Y	9.96x
Revenue Growth5 Y	10.95x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	INR 335.2B
Debt	INR 46.3B
Debt EBITDA	INR 0.28
Debt Equity	INR 0.06
Debt FCF	INR 0.53
Equity	INR 838.8B
Interest Coverage	37.93
Net Cash	INR 288.9B
Net Cash By Market Cap	INR 6.54
Net Cash Growth	21.59%
Net Debt EBITDA	INR -1.74
Net Debt Equity	INR -0.34
Net Debt FCF	INR -3.28
Tangible Book Value	INR 601.9B
Tangible Book Value Per Share	INR 251
WACC	4.93

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.02%
Dividend Growth	0%
Dividend Growth Years	7%
Dividend per share	INR 16
Dividend Years	26
Dividend Yield	0.83%
Ex Div Date	2026-07-07
Last Dividend	INR 5
Payout Frequency	Semi-Annual

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	151.53%
1Y total return	16.56%
200-day SMA	1,804.7
3Y total return	67.31%
50-day SMA	1,929.1
50-day SMA vs 200-day SMA	50over200
5Y total return	149.09%
All Time High	2,046.9
All Time High Change	-10.08%
All Time High Date	2026-07-31
All Time Low	1.65
All Time Low Change	111,445.45%
All Time Low Date	1996-11-22
ATR	32.56
Beta	0.12
Beta1y	-0.16
Beta2y	0.13
Ch YTD	7.02
High	1,854.5
High52	2,046.9
High52 Date	2026-07-31
High52ch	-10.08%
Low	1,834
Low52	1,548
Low52 Date	2025-09-26
Low52ch	18.9%
Ma50ch	-4.59%
Price vs 200-day SMA	1.98%
RSI	34
RSI Monthly	56.21
RSI Weekly	49.35
Sharpe ratio	0.68x
Sharpe Ratio3y	0.81x
Sharpe Ratio5y	0.81x
Sortino ratio	1.35
Sortino Ratio3y	1.5
Sortino Ratio5y	1.55
Total Return	0.85%
Tr YTD	8
Tr15y	745.38%
Tr1m	-5.34%
Tr1w	-3.08%
Tr3m	3.3%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,064,916,349%
Net Borrowing	17,605,100,000
Shares Insiders	12.01%
Shares Institutions	29.4%
Shares Out	2,399,334,970
Shares Qo Q	-0.39%
Shares Yo Y	-0.02%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	1,517,189.05x
Bv Per Share	348.3
CAPEX	INR -36.1B
Ch10y	130.8
Ch15y	662.5
Ch1m	-5.34
Ch1w	-3.08
Ch1y	15.51
Ch20y	1,902.2
Ch3m	3.03
Ch3y	62.81
Ch5y	137.1
Ch6m	1.53
Change	-1.1%
Change From Open	-0.24
Close	1,861
Days Gap	-0.86
Depreciation Amortization	27,867,475,000
Dollar Volume	2,659,546,426.5
Earnings Date	2026-10-30
EBIT	INR 138B
EBITDA	INR 165.8B
EPS	INR 50.4
F Score	4
FCF	INR 88.1B
FCF EV Yield	2.13x
FCF Per Share	INR 36.72
Financing CF	-25,125,500,000
Fiscal Year End	March
Founded	1,983
Graham Number	628.47561
Graham Upside	-65.85
Income Tax	INR 38.7B
Investing CF	-113,440,500,000
Is Primary Listing	1
Last Earnings Date	2026-07-31
Last Report Date	2026-06-30
Last Split Date	2013-07-29
Last Split Type	Forward
Lynch Fair Value	INR 758
Lynch Upside	-58.82
Ma150	1,829
Ma150ch	0.63%
Ma20	1,901.8
Ma20ch	-3.22%
Net CF	-4,982,600,000
Next Earnings Date	2026-10-30
Open	1,845
P FCF Ratio	50.11
P OCF Ratio	35.55
Payment Date	2026-08-07
Position In Range	31.71
Price Date	2026-09-11
Price EBITDA	INR 26.62
Ptbv Ratio	7.33
Relative Volume	0.96x
Revenue	599,105,200,000x
Tax By Revenue	6.46x
Tax Rate	24.22%
Tr20y	2,395.97%
Tr6m	1.79%
Volume	1,445,013

NSE/SUNPHARMA (NSE/SUNPHARMA)

Price

Financial snapshot

Fair-value bridge

Latest news · NSE/SUNPHARMA

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All NSE/SUNPHARMA indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on NSE/SUNPHARMA

Frequently asked questions